Resources
About Us
The IVD Assay Development Market was valued at $4.60 billion in 2023. This market is projected to reach $8.39 billion by 2031 from an estimated $4.93 billion in 2024, at a CAGR of 7.9% during the forecast period of 2024-2031. IVD Assay Development Market Size & Forecast Key factors driving the growth ...
The Global Minimal Residual Disease Testing Market is expected to reach $4.45 billion by 2031, at a CAGR of 14.6% from 2024 to 2031. Minimal Residual Disease Testing Market Size & Forecast The growth of global minimal residual disease testing market is driven by the growing incidence of cancer, the ...
Autoimmune Disease Diagnostics Market Size & Forecast The Autoimmune Disease Diagnostics Market is projected to reach $10.55 billion by 2031, at a CAGR of 7.2% in the forecast period of 2024–2031. The growth of the autoimmune disease diagnostics market is driven by the increasing prevalence of autoimmune ...
The Rapid Diagnostics Market was valued at $14.74 billion in 2023. This market is expected to reach $22.65 billion by 2031 from an estimated $14.57 billion in 2024, at a CAGR of 6.5% during the forecast period from 2024 to 2031. Rapid Diagnostics Market Size & Forecast RDT kits are extensively utilized ...
The China Microarray Market was valued at $479.8 million in 2023. This market is expected to reach $910.4 million by 2031 from an estimated $518.2 million in 2024, at a CAGR of 8.4% during the forecast period from 2024 to 2031. China Microarray Market Size & Forecast The growth of the China microarray ...
The Saudi Arabia NGS Market was valued at $ 24.4 million in 2023. This market is anticipated to reach $50 million by 2031 from an estimated $ 25.5 million in 2024, at a CAGR of 10.1% during the forecast period from 2024 to 2031. Saudi Arabia NGS Market Size & Forecast Key factors driving the growth ...
The In Vitro Diagnostics (IVD) Market was valued at $77 billion in 2023. This market is expected to reach $116.3 billion by 2031 from an estimated $80.9 billion in 2024, at a CAGR of 5.3% during the forecast period from 2024 to 2031. IVD Market Size & Forecast The growth of the In Vitro Diagnostics ...
Immunohistochemistry Market Size & Forecast The Immunohistochemistry Market is anticipated to reach $4.08 billion by 2031 at a CAGR of 7.2% from 2024–2031. A multitude of factors drives the growth of the immunohistochemistry market. These include the increasing prevalence of chronic diseases, particularly ...
The ELISA Market was valued at $20.49 billion in 2023. This market is expected to reach $32.69 billion by 2031 from an estimated $21.63 billion in 2024, at a CAGR of 6.1% during the forecast period 2024-2031 ELISA Market Size & Forecast The growth of the ELISA market is primarily driven by the high ...
The Microarray Kits Market was valued at $1.6 billion in 2023. This market is expected to reach $2.51 billion by 2031, from an estimated $1.7 billion in 2024, at a CAGR of 5.8% during the forecast period 2024-2031. Microarray Kits Market Size & Forecast Microarray kits are used in the detection ...
The Biochemical Reagents Market was valued at $24.09 billion in 2023. This market is expected to reach $39.61 billion by 2031, from an estimated $25.66 billion in 2024, at a CAGR of 6.4% during the forecast period 2024-2031. Biochemical Reagents Market Size & Forecast Biochemical reagents are ...
The Protein Assays Market was valued at $2.14 billion in 2023. This market is expected to reach $4.36 billion by 2031, from an estimated $2.34 billion in 2024, at a CAGR of 9.3% during the forecast period 2024-2031. Protein Assays Market Size & Forecast Protein assays are used for the measurement ...
The Europe Molecular Diagnostics Market is projected to reach $13.25 billion by 2030, at a CAGR of 4% from 2024 to 2030. Molecular diagnostics is a branch of medical and clinical laboratory science that involves the detection, identification, and measurement of specific genetic or molecular markers within ...
The North America Molecular Diagnostics Market is expected to reach $18.13 billion by 2030 at a CAGR of 5.3% from 2024 to 2030. Molecular diagnostics help detect the targeted genetic material in human, viral, and bacterial genomes. Molecular diagnostic tests are increasingly being used in many areas, ...
The Asia-Pacific Molecular Diagnostics Market is projected to reach $11.87 billion by 2030, at a CAGR of 7.2% from 2024 to 2030. Molecular diagnostics help detect the targeted genetic material in human, viral, and bacterial genomes. Molecular diagnostic tests are increasingly used in many areas, including ...
The Europe IVD Market is expected to reach $39.77 billion by 2030 at a CAGR of 3.7% from 2024 to 2030. In vitro diagnostics (IVD) are tests performed on biological samples such as blood, saliva, and other tissues taken from the human body to detect a wide range of diseases. IVD tests are used to screen ...
Multiplex Assays Market Size & Forecast The Multiplex Assays Market is expected to reach $6.80 billion by 2031 at a CAGR of 8.9% from 2024 to 2031. Multiplex assays are a form of immunoassay that measures several analytes at once. These assays are derived from the conventional ELISA technology, which ...
Europe Point-of-Care Diagnostics Market is expected to reach $12.98 billion by 2030, at a CAGR of 4.1% during the forecast period 2024–2030. Point-of-care diagnostics, or bedside tests, are diagnostic tests performed on-site by healthcare professionals. These tests provide quick and accurate results ...
The Europe DTC Laboratory Testing Market is projected to reach $1.59 billion by 2030, at a CAGR of 10.8% from 2024 to 2030. Direct-to-consumer, DTC tests, or at-home genetic tests, are medical or genetic tests that consumers can order and perform at home without the involvement of a healthcare professional. ...
The Asia-Pacific DTC Laboratory Testing Market is projected to reach $1.58 billion by 2030, at a CAGR of 12.8% from 2024 to 2030. Direct-to-consumer or DTC tests are the ones that are self-ordered by consumers without the involvement of their healthcare providers. The sample that is collected from the ...